Caresyntax
Precision surgery software company using AI for surgical data and analytics.
Funding history
| Date | Round | Amount |
|---|
| Aug 2024 | Series C Caresyntax secured a $180M Series C extension ($80M equity plus up to $100M growth debt) to scale its AI surgery platform. | $180M |
Investors
BlackRock Innovation CapitalMTIPOptum VenturesSymbiotic Capital
Similar companies in healthtech
Explore funding flow on EquityFlow →